SOLICITATION NOTICE
Q -- Stem Cell Therapeutic Outcomes Database (SCTOD) - PRESOLICATION NOTICE
- Notice Date
- 5/15/2017
- Notice Type
- Presolicitation
- NAICS
- 541611
— Administrative Management and General Management Consulting Services
- Contracting Office
- Department of Health and Human Services, Health Resources and Services Administration, Office of Acquisitions Management and Policy, 5600 Fisher Ln., Room 13A-19, Rockville, Maryland, 20857, United States
- ZIP Code
- 20857
- Solicitation Number
- 17-250-SOL-00046-SCTOD
- Archive Date
- 9/30/2017
- Point of Contact
- Veronica Dhaness, Phone: 3014435131, Jun Ji, Phone: 3019459484
- E-Mail Address
-
Vdhaness@hrsa.gov, jji@hrsa.gov
(Vdhaness@hrsa.gov, jji@hrsa.gov)
- Small Business Set-Aside
- N/A
- Description
- The purpose of this acquisition is to maintain the Stem Cell Therapeutic Outcomes Database (SCTOD), one component of the C.W. Bill Young Cell Transplantation Program (Program).. THIS IS A PRESOLICATION NOTICE ONLY - The Health Resources and Services Administration (HRSA), Health Systems Bureau is planning to issue a solicitation to maintain the Stem Cell Therapeutic Outcomes Database (SCTOD), one component of the C.W. Bill Young Cell Transplantation Program (Program). The solicitation will be issued as full and open with a period of performance of twelve (12) months plus four twelve-month option periods. The Government intends to issue a solicitation on or about June 2017. The anticipated contract type will be firm fixed price. The required services will be procured in accordance with FAR Part 15 - Contracting by Negotiation. The North American Industrial Classification System (NAICS) code for this acquisition is 541611, and the size standard is 15.0M. Description The purpose of this acquisition is to maintain the Stem Cell Therapeutic Outcomes Database (SCTOD), one component of the C.W. Bill Young Cell Transplantation Program (Program). The SCTOD contractor shall: 1 Collect and maintain information related to patients who have received stem cell therapeutic products in a standardized electronic format. This information is defined as the information necessary to conduct an ongoing evaluation of the scientific and clinical status of transplantation involving recipients of a stem cell therapeutic product from a donor; 2 Prepare and submit an annual report on patient outcomes at each transplant center; and, 3 Make scientific information available to the public in the form of summaries and data sets. The scope of data collection under this contract includes: 1 allogeneic transplantation for hematopoietic reconstitution using cells from donors not related to the patient; 2 allogeneic transplantation for hematopoietic reconstitution using cells from donors who are related to the patient; and 3 emerging clinical applications of cells derived from bone marrow, peripheral blood, and umbilical cord blood. All future information regarding this acquisition, including the solicitation and any amendments, will be distributed solely through the FedBizOpps website (www.fbo.gov). Copies of the solicitation document and its related documents, as appropriate, will be posted at this website. Interested parties are responsible for monitoring the FedBizOpps website to assure that they have the most up-to-date information regarding this acquisition. The Government will not reimburse interested parties for any costs associated with responding to this notice. For further information, please contact Veronica Dhaness, 5600 Fishers Lane, Rockville, MD 20857, (301) 443-5131 and VDhaness@hrsa.gov.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/notices/ad8cd8fd879bbf7ec866e2f3c0e62bdd)
- Record
- SN04508780-W 20170517/170515234948-ad8cd8fd879bbf7ec866e2f3c0e62bdd (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |